Why is Remedium Life falling/rising?

As of 10-Jun, Remedium Lifecare Ltd is experiencing a decline in its stock price, currently at Rs 1.25, which represents a decrease of Rs 0.06 or 4.58%. The stock has been underperforming significantly, with a consecutive fall over the last 10 days resulting in a total return of -32.43%. It is also trading below all key moving averages, indicating a bearish trend. The company has reported negative financial results, including a high Debt to EBITDA ratio of -1.00 times and a substantial decline in net sales and profits, contributing to its poor performance. Additionally, the stock has generated a staggering -90.52% return over the past year, further highlighting its struggles. In the broader market context, the Sensex has shown a positive return of +2.05% over the past week, contrasting sharply with Remedium's -20.38% return during the same period. This stark difference underscores the stock's significant underperformance relative to the benchmark. While there has been a notable increase in investor participation, as evidenced by a 5252.03% rise in delivery volume, the overall sentiment remains negative due to the company's ongoing financial difficulties and poor long-term growth prospects.